ResultsIQ

ResultsIQ › Latest results › TAKE Limited

TAKE Limited Q1 FY27 results press release summary

NSE: TAKE · BSE: 532890

Results press release of 11 Aug 2026, summarised by AI from the filing.

No forward guidance was given in the release.

Key takeaways

  1. Guidance No forward guidance was given in the release.
  2. Finance costs Finance costs fell 99.62% YoY to ₹0.07 Lakhs from ₹17.50 Lakhs, reflecting debt elimination.
  3. Longevity entry Strategic entry into longevity, biohacking and preventive healthcare, combining nutraceuticals with predictive digital tools.
  4. Risk No risks were acknowledged in the release.

Original filing on BSE

TAKE Limited Q1 FY27 results

As filed: Revenue ₹30.4 cr, EBITDA −₹0.3 cr, PAT ₹1.1 cr, EBITDA margin -0.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹30.4 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹54.2 cr, EBITDA −₹0.8 cr, PAT ₹4.4 cr, EBITDA margin -1.5%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹54.2 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +12.1% in 30 days (Nifty 500: +2.5%).
  • Q3 FY26: Revenue ₹0.0 cr, EBITDA −₹0.4 cr, PAT ₹1.1 cr. Not scored. Too small to score: quarter revenue ₹0.0 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little. Share price after the results: −17.1% in 30 days (Nifty 500: −7.8%).
  • Q2 FY26: Revenue ₹0.0 cr, EBITDA ₹0.0 cr, PAT ₹6.0 cr. Not scored. Too small to score: quarter revenue ₹0.0 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little. Share price after the results: +23.8% in 30 days (Nifty 500: +1.1%).
  • Q1 FY26: Revenue ₹0.0 cr, EBITDA −₹1.0 cr, PAT −₹1.0 cr. Not scored. Too small to score: quarter revenue ₹0.0 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little. Share price after the results: −14.9% in 30 days (Nifty 500: −3.8%).
  • H2 FY25: Revenue ₹0.0 cr, EBITDA −₹1.0 cr, PAT ₹5.0 cr. Not scored. Too small to score: half-year revenue ₹0.0 cr is below the ₹40.0 cr minimum. On a base this small, percentage changes say little. Share price after the results: −1.8% in 28 days (Nifty 500: +3.6%).
  • Q3 FY25: Revenue ₹0.0 cr, EBITDA −₹3.0 cr, PAT ₹48.0 cr. Not scored. Too small to score: quarter revenue ₹0.0 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little.
  • Q2 FY25: Revenue ₹0.0 cr, EBITDA −₹1.0 cr, PAT −₹2.0 cr. Not scored. Too small to score: quarter revenue ₹0.0 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little.

Past price moves after results do not indicate future moves. Not a recommendation.

TAKE Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.